K

Kotra Industries Bhd
KLSE:KOTRA

Watchlist Manager
Kotra Industries Bhd
KLSE:KOTRA
Watchlist
Price: 4.05 MYR -0.25%
Market Cap: 39.2m MYR
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

The Relative Value of one KOTRA stock under the Base Case scenario is hidden MYR. Compared to the current market price of 4.05 MYR, Kotra Industries Bhd is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

KOTRA Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

0.2
P/S
P/S
Price to Sales
0.2
vs History
53
vs Industry
45
Median 3Y
0.2
Median 5Y
0.2
Industry
2.4
Forward
0.1
More Details
1
P/E
P/E
Price to Earnings
1
vs History
17
vs Industry
31
Median 3Y
0.8
Median 5Y
0.8
Industry
20.5
Forward
0.8
More Details
0.6
P/OCF
P/OCF
Price to OCF
0.6
vs History
42
vs Industry
41
Median 3Y
0.6
Median 5Y
0.6
Industry
15.4
More Details
2.1
P/FCFE
P/FCFE
Price to FCFE
2.1
vs History
20
vs Industry
16
Median 3Y
1.4
Median 5Y
1
Industry
22.8
More Details
0.2
P/B
P/B
Price to Book Value
0.2
vs History
41
vs Industry
33
Median 3Y
0.2
Median 5Y
0.1
Industry
1.9
More Details
0
EV/S
EV/S
Enterprise Value to Sales
0
vs History
9
vs Industry
45
Median 3Y
-0.2
Median 5Y
-0.2
Industry
2.5
Forward
0
More Details
N/A
EV/GP
EV/GP
Enterprise Value to Gross Profit
N/A
vs History
vs Industry
48
Median 3Y
0
Median 5Y
0
Industry
4.9
More Details
0
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
0
vs History
9
vs Industry
38
Median 3Y
-0.5
Median 5Y
-0.5
Industry
12.4
Forward
0
More Details
0.1
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
0.1
vs History
9
vs Industry
38
Median 3Y
-0.6
Median 5Y
-0.6
Industry
15.5
Forward
0
More Details
0
EV/OCF
EV/OCF
Enterprise Value to OCF
0
vs History
9
vs Industry
42
Median 3Y
-0.5
Median 5Y
-0.5
Industry
14
More Details
0.2
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
0.2
vs History
9
vs Industry
18
Median 3Y
-1
Median 5Y
-0.8
Industry
17.9
More Details
0
EV/IC
EV/IC
Enterprise Value to IC
0
vs History
9
vs Industry
33
Median 3Y
-0.2
Median 5Y
-0.1
Industry
1.8
More Details

Multiples Across Competitors

KOTRA Competitors Multiples
Kotra Industries Bhd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
MY
Kotra Industries Bhd
KLSE:KOTRA
39.2m MYR 0.2 1 0 0.1
US
Eli Lilly and Co
NYSE:LLY
699.5B USD 15.5 66.1 38.5 42.5
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
368.8B USD 4.2 26.2 12.3 16.1
DK
Novo Nordisk A/S
CSE:NOVO B
1.9T DKK 6.6 19 12.5 14.3
CH
Roche Holding AG
SIX:ROG
208.7B CHF 3.6 18.2 10.2 12.1
CH
Novartis AG
SIX:NOVN
186.3B CHF 4.2 18.3 11.1 14.2
UK
AstraZeneca PLC
LSE:AZN
167.6B GBP 4 30.7 126.3 192.8
US
Merck & Co Inc
NYSE:MRK
206.3B USD 3.2 12.1 8.2 9.7
IE
Endo International PLC
LSE:0Y5F
162.4B USD 70 -55.5 259.5 650.8
FR
Sanofi SA
PAR:SAN
119.8B EUR 2.7 20.9 9.1 13.3
P/E Multiple
Earnings Growth PEG
MY
K
Kotra Industries Bhd
KLSE:KOTRA
Average P/E: 23.6
1
15%
0.1
US
Eli Lilly and Co
NYSE:LLY
66.1
49%
1.3
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
26.2
26%
1
DK
Novo Nordisk A/S
CSE:NOVO B
19
19%
1
CH
Roche Holding AG
SIX:ROG
18.2
16%
1.1
CH
Novartis AG
SIX:NOVN
18.3
16%
1.1
UK
AstraZeneca PLC
LSE:AZN
30.7
36%
0.9
US
Merck & Co Inc
NYSE:MRK
12.1
18%
0.7
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -55.5 N/A N/A
FR
Sanofi SA
PAR:SAN
20.9
28%
0.7
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
MY
K
Kotra Industries Bhd
KLSE:KOTRA
Average EV/EBITDA: 394
0
9%
0
US
Eli Lilly and Co
NYSE:LLY
38.5
30%
1.3
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
12.3
7%
1.8
DK
Novo Nordisk A/S
CSE:NOVO B
12.5
15%
0.8
CH
Roche Holding AG
SIX:ROG
10.2
8%
1.3
CH
Novartis AG
SIX:NOVN
11.1
5%
2.2
UK
AstraZeneca PLC
LSE:AZN
126.3
9%
14
US
Merck & Co Inc
NYSE:MRK
8.2
9%
0.9
IE
E
Endo International PLC
LSE:0Y5F
259.5
N/A N/A
FR
Sanofi SA
PAR:SAN
9.1
7%
1.3
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
MY
K
Kotra Industries Bhd
KLSE:KOTRA
Average EV/EBIT: 1 697.1
0.1
18%
0
US
Eli Lilly and Co
NYSE:LLY
42.5
33%
1.3
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
16.1
12%
1.3
DK
Novo Nordisk A/S
CSE:NOVO B
14.3
16%
0.9
CH
Roche Holding AG
SIX:ROG
12.1
9%
1.3
CH
Novartis AG
SIX:NOVN
14.2
8%
1.8
UK
AstraZeneca PLC
LSE:AZN
192.8
21%
9.2
US
Merck & Co Inc
NYSE:MRK
9.7
12%
0.8
IE
E
Endo International PLC
LSE:0Y5F
650.8
N/A N/A
FR
Sanofi SA
PAR:SAN
13.3
14%
0.9

See Also

Summary
KOTRA intrinsic value, competitors valuation, and company profile.
DCF Valuation
KOTRA stock valuation using Discount Cash Flow valuation method.
Relative Valuation
KOTRA stock valuation using valuation multiples.
Wall Street Estimates
KOTRA price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
KOTRA stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 244,400+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.